Letter: is there a role for infliximab biosimilar in patients with inflammatory bowel disease with secondary loss of response to infliximab innovator?

Related Articles

Letter: is there a role for infliximab biosimilar in patients with inflammatory bowel disease with secondary loss of response to infliximab innovator?

Aliment Pharmacol Ther. 2018 Nov;48(9):1037-1038

Authors: Orfanoudaki E, Drygiannakis I, Koutroubakis IE

PMID: 30318690 [PubMed – in process]

PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/30318690?dopt=Abstract